Case Studies

Leica Biosystems team of clinical and process experts conducted on site observations of processes, from the time a patient entered the biopsy suite, until the time their pathology report with diagnosis was delivered.

There is a paradigm shift in breast biopsy philosophy. In the past radiologists and clinicians used to collect as little tissue as possible for pathologists to render a diagnosis on conventional histologic H&E sections.

Histopathologic examination of adequate, minimally invasive breast core biopsy samples corresponding to an abnormal radiological finding is the standard of care prior to any therapeutic intervention or mammographic surveillance decision.